Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02383927
Brief Title: Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations

First Submitted : February 20, 2015
First Submitted that Met QC Criteria : March 3, 2015
First Posted : March 10, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : May 12, 2021
Last Update Posted : May 14, 2021